Browsing by Author Boersma, Eric

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2009The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsChalmers, John; MacMahon, Stephen; Ninomiya, Toshiharu; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ferrari, Roberto; Fox, Kim; Remme, Willem; Simoons, Maarten L.; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials, European Heart Journal (English Edition), vol.30, 11,pp 1385-1394
2010Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseChalmers, John; MacMahon, Stephen; Ninomiya, Toshiharu; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ceconi, Claudio; Danser, A H Jan; de Maat, Moniek P M; Ferrari, Roberto; Fox, Kim; Isaacs, Aaron; Remme, Willem; Simoons, Maarten L; Uitterlinden, Andre G.; van Duijn, Cock M.; Witteman, Jacqueline; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthGenetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease, European Heart Journal (English Edition), vol.31, 15,pp 1854-1864
2010Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's AgeSimes, Robert John; Boersma, Eric; de Boer, Sanneke P. M.; Granger, Christopher B.; Westerhout, Cynthia M.; Zijlstra, Felix; School of Public Health: NH&MRC Clinical Trials CentreMortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age, J A C C: Cardiovascular Interventions, vol.3, 3, 2010,pp 324-331
2006Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.Simes, Robert John; Armstrong, Paul W; Boersma, Eric; Califf, Robert M.; Díaz, Rafael; Granger, Christopher; Harrington, Robert A.; Orlandini, Andres; Paolasso, Ernesto; Pieper, Karen; Van De Werf, Frans J J; White, Harvey D; Wojdyla, Daniel; School of Public Health: NH&MRC Clinical Trials CentreOutcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes., European Heart Journal (2005), vol.27,(5),2006,pp 527-533
2011A Pharmacogenetic Analysis of Determinants of Hypertension and Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Vascular Disease and Healthy IndividualsChalmers, John; McMahon, Stephen; Ninomiya, Toshiharu; Akkerhuis, K Martin; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Cambien, François A.; Ceconi, Claudio; Danser, A H Jan; de Maat, Moniek P M; Ferrari, Roberto; Fox, Kim; Harrap, Stephen B.; Isaacs, Aaron; Remme, Willem; Simoons, Maarten L; Uitterlinden, Andre G.; van Duijn, Cock M.; Witteman, Jacqueline; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthA Pharmacogenetic Analysis of Determinants of Hypertension and Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Vascular Disease and Healthy Individuals, Journal of Hypertension, vol.29, 3, 2011,pp 509-519
2002Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsSimes, Robert John; Armstrong, Paul W; Boersma, Eric; Califf, Robert M; Harrington, Robert A; Moliterno, David J; Simoons, Maarten L.; Theroux, Pierre; Topol, Eric J; Torbal, Anneke de; Van de Werf, Frans; Wallentin, Lars C; White, Harvey D; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials CentrePlatelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials, The Lancet, vol.359,(9302),2002,pp 189-198
2007Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trialSimes, Robert John; Boersma, Eric; de Boer, Menko-Jan; Granger, Christopher B.; Grines, Cindy L.; Ottervanger, Jan Paul; Primary Coronary Angioplasty vs Thrombolysis–2 Trialists, Collaborators Group; Timmer, Jorik R.; Westerhout, Cynthia M.; Zijlstra, Felix; School of Public Health: NH&MRC Clinical Trials CentrePrimary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial, Archives of Internal Medicine 2005, vol.167,(13),2007,pp 1353-1359
2017The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS TrialsChalmers, John; MacMahon, Stephen William; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ferrari, Roberto; Fox, Keith; Remme, W.; Simoons, Maarten L.; The George Institute for Global Health; The George Institute for Global HealthThe Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials, Cardiovascular Drugs and Therapy, vol.31, 4, 2017,pp 391-400